Skip to content
Search

Latest Stories

Sajid Javid lauds community pharmacy for doing an ‘amazing job’ over the entire pandemic

Health secretary Sajid Javid has acknowledged and appreciated the hard work done by community pharmacies in serving people during the Covid-19 pandemic.

“Community pharmacies have done an absolutely amazing job over the entire pandemic right from day one,” he said, on the sidelines of a roundtable held at the Department of Health and Social Care in central London on September 28.


“They were on the frontline, they stayed open when many other businesses, we understand, had to be closed, because they're more than a business. They are part of your community serving critical needs.”

He added that during the pandemic, community pharmacies stepped up to deliver more than their routine services, by providing additional care in several ways and advising the country that was in a state of shock at the start of the crisis.

Javid said: “We didn't have the answer. So first of all, I can't thank community pharmacists enough for what they've been doing throughout the pandemic – when it comes to helping with vaccination programme, or in other ways.

“We absolutely need to make sure that they're getting the support that they need. We constantly keep it under review.”

Meetings with sector leaders

Health secretary Javid informed that he often meets with community pharmacy leaders to discuss their needs.

“I think that dialogue is important to make sure that we're listening and doing everything.”

Talking about the success of Covid vaccination drive in the country, he said: “Britain has been a leader in vaccine uptake. But it's been uneven.”

The national vaccination data shows the uptake of more than 80 per cent for a double dose, but a community-based segregation shows a different picture.

Vaccine uptake

Vaccination uptake amongst the British Indian community stands at 70 per cent, and for the British Pakistani community, it's about 55 per cent.

Javid said: “It has improved a lot in the last couple of months. But I wanted to certainly encourage more people to take up the offered vaccine, if you're eligible. Please take it because we know it saves lives when it protects those people around you, and not just those who are taking the vaccine.”

He added that all medical organisations including the British Medical Association agree on this that “the vaccine works.”

“There are 200,000 or fewer people in hospital because of the vaccines, there are 126,000 fewer deaths because of the vaccines and that really has got to be a central message.

To be able to say goodbye to this pandemic at some point in the future “we just need more people to take up the vaccine if it is offered to them.”

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less